InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,298.29
(
0.08%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

RKInvHub

Send PM Follow Ignore
Followers 1
Posts 28
Boards Moderated 0
Alias Born 04/28/2011

RKInvHub

Re: RKInvHub post# 96385

Tuesday, 02/21/2017 10:21:34 AM

Tuesday, February 21, 2017 10:21:34 AM

Post# of 97239
EYEG trading 65%+ higher on expanded partnership agreement with Valeant for EGP-437 in post-operative pain indication.
Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients
Could be a good sign for potential successful outcome out of the upcoming trial results in uveitis.

Sold 1/3rd @2.36 (from 1.69). Planning to sell another 1/3rd off @2.9x
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up